Skip to main content

Table 4 Association of TyG index and PCAT attenuation with severity of CAD

From: Insulin resistance and coronary inflammation in patients with coronary artery disease: a cross-sectional study

Characteristics

Model 1

Model 2

Model 3

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

L-TyG index/L-PCAT attenuation

1 (Reference)

1 (Reference)

1 (Reference)

L-TyG index/H-PCAT attenuation

1.394 (0.791, 2.459)

0.251

1.252 (0.703, 2.230)

0.445

1.281 (0.711, 2.307)

0.410

H-TyG index/L-PCAT attenuation

1.369 (0.882, 2.126)

0.162

1.423 (0.910, 2.226)

0.122

1.329 (0.835, 2.116)

0.231

H-TyG index/H-PCAT attenuation

3.621 (2.117, 6.195)

< 0.001

3.579 (2.079, 6.161)

< 0.001

3.199 (1.826, 5.607)

< 0.001

P value for trend

< 0.001

< 0.001

< 0.001

P value for interaction

0.101

0.077

0.116

  1. Model 1: unadjusted;
  2. Model 2: adjusted for age and sex;
  3. Model 3: adjusted for age, sex, BMI, smoking, hypertension, eGFR, antiplatelet drug use, statin drug use, ACEI/ARB drug use, beta-blocker drug use, and antidiabetic drug use
  4. PCAT, pericoronary adipose tissue; CAD, coronary artery disease; L, low; H, high; TyG, triglyceride-glucose; OR, odds ratio; CI, confidence interval; BMI, body mass index; eGFR, estimated glomerular filtration rate; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840